NICE judged that ‘more data is needed to be certain that these technologies do not incorrectly detect or miss skin cancer in ...

PathAI has launched the PathAssist Derm AI tool, which is designed for orienting, detecting, and measuring skin lesions. This ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

My three suspicious lesions took less than 30 seconds ... And to make things even speedier, Skin Analytics is aiming for DERM to eventually function via selfie alone, with the tool ideally ...

today announced the launch of PathAssist Derm, an AI tool for orienting, identifying, and measuring skin lesions. Available now on the AISight® Image Management System (IMS), this research tool ...

Teaser: Off-label systemic agents may treat inflammatory autoimmune vulvar diseases such as lichen sclerosus and lichen ...

Available now on the AISight® Image Management System (IMS), this research tool enables identification of skin lesions based on possible entities in the specimen with the potential to help expedite ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...